Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

PURPOSE: To evaluate the safety and feasibility of the addition of pamidronate to chemotherapy for treatment of osteosarcoma. PATIENTS AND METHODS: We treated 40 patients with osteosarcoma with cisplatin, doxorubicin, and methotrexate with the addition of pamidronate 2 mg/kg/dose (max dose 90 mg) mo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Meyers, P. A., Healey, J. H., Chou, A. J., Wexler, L. H., Merola, P. R., Morris, C. D., Laquaglia, M. P., Kellick, M. G., Abramson, S. J., Gorlick, R.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3059356/
https://ncbi.nlm.nih.gov/pubmed/21472721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25744
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items